《大行報告》麥格理上調康師傅(00322.HK)目標價至19元 評級「跑贏大市」
麥格理以「谷底反彈」(Bottoming out)為題發表報告,指康師傅(00322.HK)原材料價格通脹放緩和及加價行動,相信最壞的情況已經過去,而且股息率很有吸引力,約有9%,管理層重申今年高單位數收入增長目標。該行將估值延展至2023年,同以預測市盈率25倍為估值基礎,目標價由15.8元上調20%至19元,評級「跑贏大市」,並將該股票添至麥格理投資名單(Marquee Buy Idea)。
麥格理將康師傅2022至2023年淨利潤預測分別下調10.3%和13.8%,以反映成本壓力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.